Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MCRBSeres Therapeutics, Inc.

Nasdaq · CIK 0001609809
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts356

Identity from submissions API

NameSeres Therapeutics, Inc.
CIK0001609809
TickersMCRB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN274326290
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617 945 9626
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Seres Therapeutics, Inc. (2015-01-09T05:00:00.000Z → 2026-11-17T05:00:00.000Z)
  • Seres Health, Inc. (2014-06-09T04:00:00.000Z → 2015-05-14T04:00:00.000Z)
Business address
200 SIDNEY STREET
CAMBRIDGE
MA
02139
MA
Mailing address
200 SIDNEY STREET
CAMBRIDGE
MA
02139
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

728 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 4 0001193125-26-465539 11155
2026-11-17 4 4 0001193125-26-465538 11136
2026-11-17 4 4 0001193125-26-465537 11100
2026-11-17 4 4 0001193125-26-465536 11312
2026-11-04 10-Q 10-Q 0001193125-26-446427 001-37465 261520477 34 10087580 1 1
2026-11-04 8-K 8-K 2.02,7.01,9.01 0001193125-26-446185 001-37465 261520009 34 7747284 1 1
2026-10-26 8-K 8-K 5.02 0001193125-26-432004 001-37465 261486316 34 136375 1 1
2026-08-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002733 333-298309 261306254 33 1803
2026-08-18 4 4 0001193125-26-355734 11214
2026-08-18 4 4 0001193125-26-355722 11100
2026-08-18 4 4 0001193125-26-355718 11311
2026-08-18 4 4 0001193125-26-355712 11135
2026-08-13 S-3 S-3 0001193125-26-349330 333-298309 261274079 33 1202566 1 1
2026-08-05 10-Q 10-Q 0001193125-26-334174 001-37465 261241824 34 9502764 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-333820 001-37465 261241292 34 241903 1 1
2026-08-04 8-K 8-K 1.01,1.02,9.01 0001193125-26-332742 001-37465 261238421 34 283441 1 1
2026-08-04 424B5 424B5 0001193125-26-332730 333-273794 261238370 33 399042
2026-07-10 4 4 0001193125-26-300927 5440
2026-07-10 4 4 0001193125-26-300925 5508
2026-07-10 4 4 0001193125-26-300923 5667
2026-07-10 4 4 0001193125-26-300922 5525
2026-07-10 4 4 0001193125-26-300921 5472
2026-07-10 4 4 0001193125-26-300920 5442
2026-07-10 4 4 0001193125-26-300918 5447
2026-07-10 4 4 0001193125-26-300916 5431
2026-07-10 4 4 0001193125-26-300926 5432
2026-07-10 4 4 0001193125-26-300924 5458
2026-07-10 4 4 0001193125-26-300919 5429
2026-07-10 4 4 0001193125-26-300914 5467
2026-07-09 S-8 S-8 0001193125-26-299675 333-297341 261165736 33 282899 1 1
2026-07-08 8-K 8-K 5.02,5.07,9.01 0001193125-26-298525 001-37465 261162443 34 274207 1 1
2026-07-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-298005 001-37465 261160791 34 8110702 1 1
2026-07-02 4 4 0001193125-26-295071 5763
2026-07-02 4 4 0001193125-26-295064 5760
2026-07-02 4 4 0001193125-26-295059 5752
2026-06-05 8-K 8-K 1.01,7.01,9.01 0001193125-26-258366 001-37465 261066848 34 268109 1 1
2026-06-01 8-K 8-K 5.02 0001193125-26-251548 001-37465 261051499 34 133748 1 1
2026-05-19 144 xsl144X01/primary_doc.xml 0001950047-26-004748 001-37465 26998936 33 6193
2026-05-19 4 4 0001193125-26-230733 11100
2026-05-19 4 4 0001193125-26-230728 11134
2026-05-19 4 4 0001193125-26-230732 11030
2026-05-19 4 4 0001193125-26-230727 11304
2026-05-05 10-Q 10-Q 0001193125-26-205434 001-37465 26941173 34 7592254 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-205009 001-37465 26940395 34 224158 1 1
2026-04-27 DEFA14A DEFA14A 0001140361-26-017092 001-37465 26901003 34 1286356
2026-04-27 DEF 14A DEF 14A 0001193125-26-182036 001-37465 26900843 34 6834045 1 1
2026-03-17 144 xsl144X01/primary_doc.xml 0001950047-26-002749 001-37465 26762948 33 5695
2026-03-16 8-K 8-K 8.01 0001193125-26-108482 001-37465 26757485 34 134205 1 1
2026-03-12 10-K 10-K 0001193125-26-103276 001-37465 26746057 34 16512331 1 1
2026-03-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-103034 001-37465 26745617 34 6001748 1 1
2026-03-11 4 4 0001193125-26-102617 5329
2026-03-11 3 3 0001193125-26-102609 31197
2026-03-06 4 4 0001193125-26-096711 5318
2026-03-06 4 4 0001193125-26-096700 5471
2026-03-06 4 4 0001193125-26-096692 5332
2026-03-06 4 4 0001193125-26-096678 5352
2026-03-02 8-K 8-K 5.02,9.01 0001193125-26-085368 001-37465 26707506 34 458691 1 1
2026-02-18 4 4 0001193125-26-057156 10963
2026-02-18 4 4 0001193125-26-057157 11082
2026-02-18 4 4 0001193125-26-057154 11040
2026-02-18 4 4 0001193125-26-057153 11167
2025-11-18 4 4 0001193125-25-286236 15968
2025-11-18 4 4 0001193125-25-286235 12332
2025-11-18 4 4 0001193125-25-286240 12409
2025-11-18 4 4 0001193125-25-286226 16053
2025-11-05 10-Q 10-Q 0001193125-25-266011 001-37465 251452165 34 11218952 1 1
2025-11-05 8-K 8-K 2.02,7.01,9.01 0001193125-25-265708 001-37465 251451741 34 5677057 1 1
2025-10-03 8-K 8-K 8.01 0001193125-25-230118 001-37465 251373792 34 137838 1 1
2025-09-30 4 4 0001193125-25-225105 5576
2025-09-30 4 4 0001193125-25-225103 5660
2025-08-19 4 4 0000950170-25-110096 12332
2025-08-19 4 4 0001193125-25-183436 12409
2025-08-19 4 4 0000950170-25-110090 12534
2025-08-19 4 4 0001193125-25-183434 12449
2025-08-06 4 4 0000950170-25-104016 5401
2025-08-06 3 3 0000950170-25-103986 17929
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002160 005-88909 251188553 34 11015
2025-08-06 10-Q 10-Q 0000950170-25-103611 001-37465 251187897 34 9595605 1 1
2025-08-06 8-K 8-K 2.02,7.01,9.01 0001193125-25-173985 001-37465 251187408 34 5750896 1 1
2025-07-22 8-K 8-K 5.02 0001193125-25-162552 001-37465 251140413 34 144413 1 1
2025-07-02 4 4 0000950170-25-093311 5616
2025-07-02 4 4 0000950170-25-093285 5630
2025-07-02 4 4 0000950170-25-093273 5681
2025-06-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001632 005-88909 251029181 34 11315
2025-05-19 4 4 0000950170-25-074328 12773
2025-05-19 4 4 0000950170-25-074327 12702
2025-05-19 4 4 0000950170-25-074325 12653
2025-05-19 4 4 0000950170-25-074323 12848
2025-05-07 S-8 S-8 0001193125-25-114886 333-287027 25921301 33 70353
2025-05-07 10-Q 10-Q 0000950170-25-065173 001-37465 25919698 34 8156661 1 1
2025-05-07 8-K 8-K 2.02,7.01,9.01 0001193125-25-114430 001-37465 25919235 34 5283053 1 1
2025-04-22 8-K 8-K 5.03,9.01 0001193125-25-089189 001-37465 25857713 34 165572 1 1
2025-04-14 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-25-080185 001-37465 25836169 34 294524 1 1
2025-04-11 4 4 0000950170-25-053250 5246
2025-04-11 4 4 0000950170-25-053249 5314
2025-04-11 4 4 0000950170-25-053248 5242
2025-04-11 4 4 0000950170-25-053247 5260
2025-04-11 4 4 0000950170-25-053246 5255
2025-04-11 4 4 0000950170-25-053245 5257
2025-04-11 4 4 0000950170-25-053243 5214
2025-04-04 DEFA14A DEFA14A 0001193125-25-072547 001-37465 25811528 34 665841 1 1
2025-03-13 DEF 14A DEF 14A 0000950170-25-038441 001-37465 25734528 34 6326038 1 1
2025-03-13 S-8 S-8 0001193125-25-053676 333-285769 25734504 33 78024
2025-03-13 10-K 10-K 0000950170-25-038427 001-37465 25734453 34 15907224 1 1
2025-03-13 8-K 8-K 2.02,7.01,9.01 0001193125-25-053473 001-37465 25733815 34 15422850 1 1
2025-03-03 PRE 14A PRE 14A 0000950170-25-030842 001-37465 25697879 34 5721101 1 1
2025-02-27 8-K 8-K 5.02 0001193125-25-039256 001-37465 25679015 34 140062 1 1
2025-02-19 4 4 0000950170-25-023584 13023
2025-02-19 4 4 0000950170-25-023580 13008
2025-02-19 4 4 0000950170-25-023575 12949
2025-02-19 4 4 0000950170-25-023573 12900
2025-02-19 4 4 0000950170-25-023569 13025
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000814 005-88909 25612439 34 11599
2025-02-11 4 4 0000950170-25-017916 5346
2025-02-11 4 4 0000950170-25-017913 5395
2025-02-11 4 4 0000950170-25-017914 5392
2025-02-11 4 4 0000950170-25-017912 5330
2025-02-11 4 4 0000950170-25-017911 5409
2025-02-11 4 4 0000950170-25-017910 5272
2025-02-06 4 4 0000950170-25-015020 5317
2025-02-06 8-K 8-K 5.02 0001193125-25-021345 001-37465 25595509 34 144969 1 1
2025-02-06 3 3 0000950170-25-015016 16843
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-005011 001-37465 25524912 34 14689636 1 1
2025-01-10 8-K 8-K 2.02,8.01,9.01 0001193125-25-004062 001-37465 25520338 34 186459 1 1
2024-11-19 4 4 0000950170-24-128631 9189
2024-11-19 4 4 0000950170-24-128626 9320
2024-11-19 4 4 0000950170-24-128613 9310
2024-11-19 4 4 0000950170-24-128609 9241
2024-11-19 4 4 0000950170-24-128611 9303
2024-11-13 10-Q 10-Q 0000950170-24-126018 001-37465 241451834 34 11313082 1 1
2024-11-13 8-K 8-K 2.02,3.01,7.01,9.01 0001193125-24-256654 001-37465 241451275 34 4638006 1 1
2024-10-29 4 4 0000950170-24-118424 9840
2024-10-29 4 4 0000950170-24-118418 9826
2024-10-29 4 4 0000950170-24-118415 9704
2024-10-29 4 4 0000950170-24-118409 9762
2024-10-29 4 4 0000950170-24-118405 9825
2024-10-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-11 16:00:00 9999999995-24-003174 333-282450 241368891 33 1810
2024-10-11 424B3 424B3 0001193125-24-236757 333-282450 241367923 33 138873
2024-10-09 CORRESP filename1.htm 0001193125-24-235165 7021
2024-10-08 UPLOAD filename1.pdf 0000000000-24-011398 333-282450 40121
2024-10-02 SC 13D/A SC 13D/A 0001193125-24-230718 005-88909 241345345 34 50869
2024-10-02 3 3 0000950170-24-111110 5929
2024-10-01 S-3 S-3 0001193125-24-230253 333-282450 241343984 33 234211
2024-10-01 8-K 8-K 1.01,1.02,2.01,3.02,7.01,9.01 0001193125-24-230144 001-37465 241343243 34 8661041 1 1
2024-09-26 8-K 8-K 5.07,9.01 0001193125-24-226929 001-37465 241329103 34 166875 1 1
2024-09-12 DEFA14A DEFA14A 0001193125-24-217668 001-37465 241293967 34 20676071
2024-09-12 8-K 8-K 7.01,8.01,9.01 0001193125-24-217627 001-37465 241293875 34 20847581 1 1
2024-08-26 DEFM14A DEFM14A 0001140361-24-038575 001-37465 241241924 34 5404689
2024-08-19 4 4 0000950170-24-098719 9187
2024-08-19 4 4 0000950170-24-098717 9320
2024-08-19 4 4 0000950170-24-098715 9301
2024-08-19 4 4 0000950170-24-098712 9241
2024-08-19 4 4 0000950170-24-098710 9309
2024-08-19 4 4 0000950170-24-098699 9314
2024-08-15 DEFA14A DEFA14A 0001140361-24-037508 001-37465 241212395 34 47598
2024-08-15 PREM14A PREM14A 0001140361-24-037423 001-37465 241210573 34 5344848
2024-08-15 8-K 8-K 7.01,9.01 0001140361-24-037388 001-37465 241210491 34 11339074 1 1
2024-08-13 DEFA14A DEFA14A 0001140361-24-037115 001-37465 241203036 34 72724
2024-08-13 10-Q 10-Q 0000950170-24-095821 001-37465 241199380 34 11215234 1 1
2024-08-13 DEFA14A DEFA14A 0001193125-24-199388 001-37465 241198746 34 3703514
2024-08-13 8-K 8-K 2.02,7.01,9.01 0001193125-24-199382 001-37465 241198736 34 3860458 1 1
2024-08-07 DEFA14A DEFA14A 0001140361-24-036031 001-37465 241181712 34 57945
2024-08-07 DEFA14A DEFA14A 0001140361-24-035971 001-37465 241181094 34 695942
2024-08-06 DEFA14A DEFA 14A 0001140361-24-035954 001-37465 241180638 34 24747
2024-08-06 DEFA14A DEFA14A 0001140361-24-035953 001-37465 241180631 34 2120445
2024-08-06 8-K FORM 8-K 1.01,1.02,3.02,9.01 0001140361-24-035951 001-37465 241180626 34 2627713 1 1
2024-08-06 4 4 0000950170-24-091832 9116
2024-08-06 DEFA14A DEFA14A 0001140361-24-035800 001-37465 241177136 34 101556
2024-08-06 8-K 8K 7.01,9.01 0001140361-24-035799 001-37465 241177132 34 266514 1 1
2024-07-03 4 4 0000950170-24-081527 5636
2024-07-03 4 4 0000950170-24-081522 5621
2024-07-03 4 4 0000950170-24-081521 5642
2024-05-17 4 4 0000950170-24-062061 9314
2024-05-17 4 4 0000950170-24-062059 9237
2024-05-17 4 4 0000950170-24-062058 9304
2024-05-17 4 4 0000950170-24-062057 9298
2024-05-17 4 4 0000950170-24-062056 9312
2024-05-17 4 4 0000950170-24-062052 9183
2024-05-08 10-Q 10-Q 0000950170-24-055159 001-37465 24924577 34 10535982 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001193125-24-133766 001-37465 24924211 34 240542 1 1
2024-05-07 8-K 8-K 2.04 0001193125-24-133298 001-37465 24923264 34 150574 1 1
2024-04-23 8-K 8-K 3.01 0001193125-24-105862 001-37465 24862664 34 147133 1 1
2024-04-08 4 4 0000950170-24-042654 5248
2024-04-08 4 4 0000950170-24-042651 5261
2024-04-08 4 4 0000950170-24-042657 5252
2024-04-08 4 4 0000950170-24-042655 5319
2024-04-08 4 4 0000950170-24-042652 5220
2024-04-08 4 4 0000950170-24-042656 5263
2024-04-08 4 4 0000950170-24-042653 5266
2024-04-08 8-K 8-K 5.03,5.07,9.01 0001193125-24-089654 001-37465 24829982 34 169291 1 1
2024-04-05 SC 13G/A us81750r1023_040424.txt 0001086364-24-007425 005-88909 24825673 34 12536
2024-03-27 4 4 0000950170-24-037213 5348
2024-03-27 3 3 0000950170-24-037195 15136
2024-03-05 DEF 14A DEF 14A 0000950170-24-025482 001-37465 24718642 34 4983269 1 1
2024-03-05 S-8 S-8 0001193125-24-058891 333-277658 24718621 33 76618
2024-03-05 10-K 10-K 0000950170-24-025464 001-37465 24718591 34 15756005 1 1
2024-03-05 8-K 8-K 2.02,9.01 0001193125-24-058584 001-37465 24718250 34 256598 1 1
2024-02-26 8-K 8-K 5.02,7.01,9.01 0001193125-24-045328 001-37465 24673523 34 185165 1 1
2024-02-23 PRE 14A PRE 14A 0000950170-24-019351 001-37465 24671118 34 4396265 1 1
2024-02-16 4 4 0000950170-24-016712 15970
2024-02-16 4 4 0000950170-24-016710 16025
2024-02-16 4 4 0000950170-24-016695 16096
2024-02-16 4 4 0000950170-24-016694 16091
2024-02-16 4 4 0000950170-24-016690 16159
2024-02-16 4 4 0000950170-24-016688 16104
2024-02-16 4 4 0000950170-24-016687 16055
2024-02-12 SC 13G/A JHG PLC OWNS <5% 0001274173-24-000012 005-88909 24618540 34 10156
2024-02-09 SC 13G/A filing.txt 0000315066-24-001491 005-88909 24612009 34 8287
2024-01-30 8-K 8-K 8.01 0001193125-24-019398 001-37465 24578116 34 142392 1 1
2024-01-29 SC 13G us81750r1023_012924.txt 0001086364-24-005618 005-88909 24574960 34 13410
2024-01-10 8-K 8-K 2.02,9.01 0001193125-24-005614 001-37465 24524846 34 194817 1 1
2024-01-09 8-K 8-K 7.01,9.01 0001193125-24-004833 001-37465 24521708 34 3708799 1 1
2024-01-02 8-K 8-K 5.03,9.01 0001193125-24-000683 001-37465 24502399 34 385957 1 1
2023-11-07 SC 13G/A form1418.htm 0001623632-23-001423 005-88909 231382710 34 359799
2023-11-02 10-Q 10-Q 0000950170-23-057805 001-37465 231370487 34 11955737 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001193125-23-268807 001-37465 231370027 34 256227 1 1
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020082 12617
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020080 12401
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020079 12443
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020077 12427
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020076 12343
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020075 12416
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020070 12455
2023-10-31 4 FORM 4 SUBMISSION 0000899243-23-020069 12439
2023-10-04 8-K 8-K 5.02 0001193125-23-250341 001-37465 231306559 34 140092 1 1
2023-08-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-15 16:00:00 9999999995-23-002400 333-273794 231176407 33 1761
2023-08-11 CORRESP filename1.htm 0001193125-23-210997 7143
2023-08-11 UPLOAD filename1.pdf 0000000000-23-008774 40306
2023-08-08 S-3 S-3 0001193125-23-206199 333-273794 231151279 33 1066203
2023-08-08 10-Q 10-Q 0000950170-23-039439 001-37465 231149678 34 13673930 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001193125-23-205557 001-37465 231149258 34 272148 1 1
2023-06-28 8-K 8-K 5.03,7.01,9.01 0001193125-23-176795 001-37465 231049200 34 10794748 1 1
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016412 5392
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016406 5403
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016402 5406
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016401 5464
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016398 5379
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016397 5388
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016396 5401
2023-06-23 4 FORM 4 SUBMISSION 0000899243-23-016395 5364
2023-06-23 8-K 8-K 5.07 0001193125-23-173803 001-37465 231037696 34 151168 1 1
2023-05-10 SC 13G/A form1031.htm 0001623632-23-000614 005-88909 23904780 34 286053
2023-05-09 10-Q 10-Q 0000950170-23-019222 001-37465 23900503 34 10828939 1 1
2023-05-09 8-K 8-K 2.02,7.01,9.01 0001193125-23-138954 001-37465 23900092 34 22738234 1 1
2023-05-01 4 FORM 4 SUBMISSION 0000899243-23-011945 7559
2023-05-01 4 FORM 4 SUBMISSION 0000899243-23-011944 5359
2023-05-01 4 FORM 4 SUBMISSION 0000899243-23-011942 5825
2023-04-27 8-K 8-K 1.01,2.02,2.03,3.02,7.01,8.01,9.01 0001193125-23-120045 001-37465 23851895 34 12463055 1 1
2023-04-25 DEFA14A DEFA14A 0000950170-23-014431 001-37465 23844988 34 346857
2023-04-25 DEF 14A DEF 14A 0000950170-23-014419 001-37465 23844880 34 6913258 1 1
2023-04-14 PRE 14A PRE 14A 0000950170-23-012906 001-37465 23821570 34 6374991 1 1
2023-04-06 SC 13G/A us81750r1023_040523.txt 0001306550-23-009015 005-88909 23804631 34 12505
2023-03-07 S-8 S-8 0001193125-23-062117 333-270319 23711052 33 86783
2023-03-07 10-K 10-K 0000950170-23-006374 001-37465 23711017 34 18022988 1 1
2023-03-07 8-K 8-K 2.02,9.01 0001193125-23-062068 001-37465 23711009 34 245894 1 1
2023-02-10 SC 13G/A JHG PLC OWNS >5% 0001274173-23-000049 005-88909 23609613 34 10466
2023-02-09 SC 13G/A filing.txt 0000315066-23-002040 005-88909 23605015 34 8205
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016931 005-88909 23604178 34 13025
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004211 8048
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004210 8053
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004208 8036
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004207 7941
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004206 8003
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004204 8022
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004200 10349
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004197 8044
2023-02-03 SC 13G/A Seres_Therapeutics_Inc.txt 0000093751-23-000179 005-88909 23585466 34 8465
2023-02-03 SC 13G us81750r1023_020323.txt 0001306550-23-007074 005-88909 23584699 34 13391
2023-02-01 SC 13G/A form831.htm 0001623632-23-000238 005-88909 23575683 34 213526
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004111 001-37465 23516502 34 10620516 1 1
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001007 5463
2023-01-05 3 FORM 3 SUBMISSION 0000899243-23-000997 7357
2023-01-05 8-K 8-K 5.02 0001193125-23-002405 001-37465 23511494 34 140556 1 1
2022-12-30 S-8 S-8 0001193125-22-315424 333-269081 221502071 33 178099
2022-12-14 8-K 8-K 1.01,9.01 0001193125-22-304803 001-37465 221462224 34 242962 1 1
2022-11-02 10-Q 10-Q 0000950170-22-021018 001-37465 221352618 34 12869953 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001193125-22-275406 001-37465 221352274 34 256553 1 1
2022-10-31 4 FORM 4 SUBMISSION 0000899243-22-034598 6954
2022-10-31 4 FORM 4 SUBMISSION 0000899243-22-034577 9192
2022-09-09 4 FORM 4 SUBMISSION 0000899243-22-030735 5900
2022-08-09 SC 13G/A us81750r1023_080822.txt 0000834237-22-010496 005-88909 221148142 34 12518
2022-08-03 10-Q 10-Q 0000950170-22-014052 001-37465 221131236 34 11050702 1 1
2022-08-03 8-K 8-K 2.02,9.01 0001193125-22-210555 001-37465 221130909 34 277436 1 1
2022-07-22 SC 13D/A SC 13D/A 0001193125-22-199872 005-88909 221099522 34 126370
2022-07-11 SC 13G/A form399.htm 0001623632-22-000832 005-88909 221076640 34 357747
2022-07-07 SC 13D/A SC 13D/A 0001193125-22-189531 005-88909 221072219 34 227727
2022-07-07 3 FORM 3 SUBMISSION 0000899243-22-025722 7096
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025721 19203
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025521 4545
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025520 4636
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025518 4647
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025516 4625
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025515 4564
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025514 4651
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025513 4524
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025509 4600
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025506 4555
2022-07-06 4 FORM 4 SUBMISSION 0000899243-22-025505 4552
2022-06-30 8-K 8-K 1.01,9.01 0001193125-22-185606 001-37465 221056549 34 776457 1 1
2022-06-30 424B5 424B5 0001193125-22-185602 333-244401 221056541 33 370497
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024013 5369
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024010 5365
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024008 5356
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024004 5360
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023992 5365
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023990 5369
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023989 5356
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023979 5347
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023974 5371
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023973 5374
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-023972 5332
2022-06-24 8-K 8-K 5.07 0001193125-22-181465 001-37465 221040025 34 146918 1 1
2022-06-07 8-K 8-K 7.01,8.01,9.01 0001193125-22-168845 001-37465 22999822 34 8552662 1 1
2022-05-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-140444,2022-05-06 9999999995-22-001340 333-244401 22903066 33 1773
2022-05-04 POS AM POS AM 0001193125-22-140444 333-244401 22891451 33 71827
2022-05-04 10-Q 10-Q 0000950170-22-007217 001-37465 22890134 34 9896666 1 1
2022-05-04 8-K 8-K 2.02,9.01 0001193125-22-139450 001-37465 22889804 34 236066 1 1
2022-04-29 DEFA14A DEFA14A 0001193125-22-133624 001-37465 22875318 34 743247
2022-04-29 DEF 14A DEF 14A 0001193125-22-133526 001-37465 22875076 34 606502
2022-04-06 8-K 8-K 7.01,9.01 0001193125-22-096755 001-37465 22809350 34 9183335 1 1
2022-03-01 POS AM POS AM 0001193125-22-060382 333-244401 22695148 33 499364
2022-03-01 S-8 S-8 0001193125-22-060244 333-263134 22694894 33 88423
2022-03-01 10-K 10-K 0000950170-22-002435 001-37465 22694656 34 16906327 1 1
2022-03-01 POSASR POSASR 0001193125-22-060153 333-244401 22694572 33 518423
2022-03-01 8-K 8-K 2.02,9.01 0001193125-22-059784 001-37465 22693910 34 276305 1 1
2022-02-14 SC 13G/A SERES THERAPEUTICS, INC. 0001104659-22-022785 005-88909 22631940 34 90326
2022-02-14 SC 13G form46.htm 0001623632-22-000239 005-88909 22629033 34 279606
2022-02-14 SC 13G/A SC13G/A 0001140361-22-005039 005-88909 22624469 34 63462
2022-02-11 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000076 005-88909 22619997 34 10571
2022-02-10 SC 13G SCHEDULE 13G 0001104659-22-018542 005-88909 22610814 34 12991
2022-02-09 SC 13G/A filing.txt 0000315066-22-001334 005-88909 22604824 34 8827
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005322 5545
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005320 5485
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005319 5479
2022-02-08 3 FORM 3 SUBMISSION 0000899243-22-005318 7228
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005317 5493
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005316 5532
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005315 5434
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005314 5381
2022-02-08 4 FORM 4 SUBMISSION 0000899243-22-005313 5476
2022-02-04 SC 13G/A AMENDMENT NO. 4 0001214659-22-001858 005-88909 22590832 34 63266
2022-02-03 SC 13G/A us81750r1023_020322.txt 0000834237-22-006301 005-88909 22589036 34 13430
2022-01-10 SC 13G/A SERES_THERAPEUTICS_INC.txt 0000093751-22-000009 005-88909 22520219 34 8481
2021-11-10 10-Q 10-Q 0000950170-21-003937 001-37465 211394813 34 11849958 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001193125-21-325227 001-37465 211394365 34 264247 1 1
2021-10-12 SC 13G Seres_Therapeutics_Inc.txt 0000093751-21-000682 005-88909 211318039 34 10323
2021-08-03 10-Q 10-Q 0000950170-21-000674 001-37465 211138308 34 8822547 1 1
2021-08-03 8-K 8-K 2.02,9.01 0001193125-21-234005 001-37465 211137957 34 258740 1 1
2021-07-22 8-K 8-K 7.01,9.01 0001193125-21-221362 001-37465 211105998 34 174191 1 1
2021-07-01 8-K 8-K 1.01 0001193125-21-205559 001-37465 211064046 34 149102 1 1
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-025000 5361
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024998 5375
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024990 5370
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024993 5333
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024995 5357
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024997 5372
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024994 5348
2021-06-21 4 FORM 4 SUBMISSION 0000899243-21-024989 5366
2021-06-21 8-K 8-K 5.07 0001193125-21-195033 001-37465 211030521 34 153125 1 1
2021-06-01 4 FORM 4 SUBMISSION 0000899243-21-021446 7973
2021-06-01 3 FORM 3 SUBMISSION 0000899243-21-021441 7622
2021-05-21 8-K 8-K 1.01,9.01 0001193125-21-169360 001-37465 21949703 34 404973 1 1
2021-05-21 424B5 424B5 0001193125-21-169353 333-244401 21949648 33 392658
2021-05-20 8-K 8-K 5.02,7.01,9.01 0001193125-21-167279 001-37465 21942434 34 340387 1 1
2021-05-19 4 FORM 4 SUBMISSION 0000899243-21-020015 15154
2021-05-05 SC 13G SCHEDULE 13G 0001104659-21-061778 005-88909 21894034 34 87703
2021-05-04 10-Q 10-Q 0001564590-21-023017 001-37465 21886364 34 8078678 1 1
2021-05-04 8-K 8-K 2.02,9.01 0001193125-21-149022 001-37465 21886035 34 250878 1 1
2021-04-30 DEFA14A DEFA14A 0001193125-21-145026 001-37465 21877943 34 243143
2021-04-30 DEF 14A DEF 14A 0001193125-21-144988 001-37465 21877845 34 584826
2021-03-03 S-8 POS S-8 POS 0001193125-21-065971 333-253776 21706072 33 53518
2021-03-02 S-8 S-8 0001193125-21-064827 333-253776 21701617 33 62231
2021-03-02 10-K 10-K 0001564590-21-010057 001-37465 21701498 34 14165937 1 1
2021-03-02 8-K 8-K 2.02,9.01 0001193125-21-064509 001-37465 21701259 34 251948 1 1
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-024169 005-88909 21639386 34 61652
2021-02-11 SC 13G/A SC 13G/A 0001140361-21-004419 005-88909 21621104 34 63053
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005255 5382
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005254 8046
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005250 5494
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005247 5477
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005245 5435
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005242 5477
2021-02-08 SC 13G/A filing.txt 0000315066-21-001287 005-88909 21599833 34 8390
2021-02-05 SC 13G/A AMENDMENT NO. 3 0001214659-21-001387 005-88909 21593366 34 63409
2021-02-01 SC 13G/A us81750r1023_013121.txt 0000834237-21-005692 005-88909 21574741 34 13329
2021-02-01 8-K 8-K 5.02,9.01 0001193125-21-023645 001-37465 21574305 34 501254 1 1
2021-01-11 8-K 8-K 7.01,9.01 0001193125-21-005753 001-37465 21519077 34 10467224 1 1
2020-12-07 8-K 8-K 1.02,5.03,9.01 0001193125-20-311141 001-37465 201371315 34 386278 1 1
2020-12-03 4 FORM 4 SUBMISSION 0000899243-20-032667 21090
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032202 5037
2020-11-25 4 FORM 4 SUBMISSION 0000899243-20-032200 34289
2020-11-25 SC 13D/A SC 13D/A 0001193125-20-303667 005-88909 201351033 34 189354
2020-11-20 8-K 8-K 7.01,9.01 0001193125-20-298701 001-37465 201330467 34 12764544 1 1
2020-11-09 10-Q 10-Q 0001564590-20-052273 001-37465 201296410 34 9188436 1 1
2020-10-21 4 FORM 4 SUBMISSION 0000899243-20-028909 5487
2020-10-21 3 FORM 3 SUBMISSION 0000899243-20-028908 7068
2020-10-09 SC 13G/A SC 13G/A 0001104659-20-113858 005-88909 201232911 34 46490
2020-09-10 SC 13G/A filing.txt 0000315066-20-001720 005-88909 201167935 34 8391
2020-09-09 SC 13G/A AMENDMENT NO. 2 0001214659-20-007732 005-88909 201165301 34 63673
2020-09-08 SC 13G/A SC 13G/A 0001140361-20-019924 005-88909 201163745 34 64683

Latest XBRL company facts

One latest value per concept from companyfacts (356 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 10.20M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
dei EntityPublicFloat Entity Public Float USD 71.94M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-103276
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 900,283 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182036
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.02M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182036
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 13 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182036
ffd NetFeeAmt NetFeeAmt USD 9,026.84 2026-08-13 S-3 2026-08-13 0001193125-26-349330
ffd TtlFeeAmt TtlFeeAmt USD 9,026.84 2026-08-13 S-3 2026-08-13 0001193125-26-349330
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-08-13 S-3 2026-08-13 0001193125-26-349330
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-13 S-3 2026-08-13 0001193125-26-349330
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-13 S-3 2026-08-13 0001193125-26-349330
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 183,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 14.63M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 462,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 29.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266011
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.86M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2.79M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.58M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap AssetRetirementObligation Asset Retirement Obligation USD 452,000 2022-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap Assets Assets USD 65.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AssetsCurrent Assets, Current USD 34.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2022-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 13,000 2022-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 18.32M 2022-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 75.00M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 59,000 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 104,000 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 75.10M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 18.32M 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 18.31M 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 18.31M 2022-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 2.40M 2020-06-30 2020 Q2 10-Q 2020-07-28 0001564590-20-033715
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 26,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284924
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 3,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284924
us-gaap BilledContractReceivables Billed Contracts Receivable USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-334174
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 17.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -18.45M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 272.55M 2021-03-31 2021 Q1 10-Q 2021-05-04 0001564590-21-023017
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 20.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -33.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 66.49M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039439
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 360.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 10.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 10.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 5.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 4.83M 2019-12-31 2020 FY 10-K 2021-03-02 0001564590-21-010057
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 4.83M 2019-12-31 2020 FY 10-K 2021-03-02 0001564590-21-010057
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 136.05M 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028938
us-gaap DebtInstrumentConvertibleThresholdTradingDays Debt Instrument, Convertible, Threshold Trading Days TradingDays 30 2023-04-27 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 15,000 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014692
us-gaap DeferredIncome Deferred Income USD 7.73M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 19.82M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.68M 2014-12-31 2015 Q3 10-Q 2015-11-12 0001564590-15-010634
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 2.22M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 50,000 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 330.78M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 167.20M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 98,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.22M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 54.15M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 28.59M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.79M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 310.96M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 50.56M 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 592,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2016-01-01 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2016-01-01 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 8.67M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current USD 58.10M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredRevenueNoncurrent Disposal Group, Including Discontinued Operation, Deferred Revenue, Noncurrent USD 95.36M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationInventoryCurrent Disposal Group, Including Discontinued Operation, Inventory, Current USD 29.65M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent USD 39.17M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 1.07M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent USD 4.84M 2023-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 24.96M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019222
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.61 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007217
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.602 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure -0.198 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.541 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.058 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.07M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 57.91M 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 9.99M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007217
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007217
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.912 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.024 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -7,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -103,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -354,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -469,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 20.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 1.54M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2023-01-01 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 11.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 5.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -35.15M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001564590-15-010634
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 0.64 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -3.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2022-09-30 2022 Q3 10-Q 2022-11-02 0000950170-22-021018
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -3.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Amount USD -1.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 14,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 3.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -67,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -334,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -221,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 43.02M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -4.36M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -16.33M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.19M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001564590-21-010057
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 113,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 1.29M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap InterestExpenseDebt Interest Expense, Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap InterestExpenseOther Interest Expense, Other USD 969,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 958,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 744,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040255
us-gaap InterestIncomeOther Interest Income, Other USD 696,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018757
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap InventoryNet Inventory, Net USD 29.65M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 4.43M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 25.22M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap InventoryWriteDown Inventory Write-down USD 0 2023-01-01 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 652,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LeaseCost Lease, Cost USD 13.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 1.86M 2021-09-01 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 49.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 25.32M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 13.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 11.54M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 13.58M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap Liabilities Liabilities USD 44.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 65.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 863,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap LiabilitiesCurrent Liabilities, Current USD 20.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040255
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 25.00M 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap LongTermDebt Long-term Debt USD 110.00M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 19.25M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 33.00M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 33.00M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 24.75M 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-095821
us-gaap LongTermInvestments Long-term Investments USD 0 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2016-09-30 2016 Q3 10-Q 2016-11-10 0001564590-16-028938
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -165,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 12.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 38.03M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -49.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -26.76M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -31.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -31.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -31.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD -26.86M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 26.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingExpenses Operating Expenses USD 60.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -58.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeaseCost Operating Lease, Cost USD 10.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 35.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 12.65M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 23.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeasePayments Operating Lease, Payments USD 21.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 27.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 30.21M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.34M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.16M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6.37M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.22M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 6.12M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008002
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 5.16M 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 6.34M 2018-12-31 2019 Q3 10-Q 2019-11-05 0001564590-19-040255
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.095 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 951,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 31,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD 12,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 137,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028339
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 514,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OtherNoncashExpense Other Noncash Expense USD 367,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014692
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 981,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001564590-21-010057
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 26.79M 2023-01-01 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap PaymentsForOperatingActivities Payments for Operating Activities USD 73.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 33,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 2.93M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap PaymentsForRestructuring Payments for Restructuring USD 193,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 1.22M 2022-04-01 2022-04-30 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 425,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.28M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 197,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-02 0001564590-21-010057
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 15.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 10.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 267.76M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014692
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 96.72M 2022-06-29 2022 Q3 10-Q 2022-11-02 0000950170-22-021018
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD -24,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-10 0001193125-15-284924
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 27.61M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006374
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 50.45M 2023-04-27 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 2.00M 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-12 0001564590-15-010634
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 39,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 32.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred USD 3.60M 2025-07-01 2025-07-31 2025 Q3 10-Q 2025-11-05 0001193125-25-266011
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 27.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestrictedCash Restricted Cash USD 3.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 113,000 2018-12-31 2018 FY 10-K 2019-03-06 0001564590-19-006423
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 2.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 773,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 160 2023-11-02 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.3 2026-02-12 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestructuringCharges Restructuring Charges USD 914,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RestructuringReserve Restructuring Reserve USD 0 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052273
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.00B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 351,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266011
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 205,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012140
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 26.92M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001564590-19-006423
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 151.00M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018757
us-gaap Revenues Revenues USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap SecurityDeposit Security Deposit USD 119,000 2016-09-30 2018 FY 10-K 2019-03-06 0001564590-19-006423
us-gaap SeveranceCosts1 Severance Costs USD 718,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 659,524 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 83.6 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 98,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 191,467 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 777,579 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 193,282 2018-12-31 2018 FY 10-K 2019-03-06 0001564590-19-006423
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 39.63 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 39.63 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001193125-26-205434
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 80.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 8.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap SharePrice Share Price USD/shares 21 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap ShortTermInvestments Short-term Investments USD 0 2023-12-31 8-K 2024-08-15 0001140361-24-037388
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 21.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 20 2025-04-10 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 714,285 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 136.05M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 11,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 96.72M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 153,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015070
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -33,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 15,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap SubleaseIncome Sublease Income USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007217
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -1.29M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-14 0001564590-16-014692
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 1.29M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2016-03-31 2016 Q1 10-Q 2016-05-16 0001564590-16-019550
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2016-03-31 2016 Q1 10-Q 2016-05-16 0001564590-16-019550
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2016-03-31 2016 Q1 10-Q 2016-05-16 0001564590-16-019550
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2016-03-31 2016 Q1 10-Q 2016-05-16 0001564590-16-019550
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002435
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 13.86M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 289,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 129,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103276
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 486,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-13 0000950170-25-038427
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 40.68M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004830
us-gaap VariableLeaseCost Variable Lease, Cost USD 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 0 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004551
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 9.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 92.16M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007217
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 9.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446427

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →